Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
Phillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Science Advances
|
May 4, 2022
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
Matthew D Gray, Junli Feng, Connor E Weidle, et al.
Cell Reports
|
May 5, 2021
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
Emilie Seydoux, Yu-Hsin Wan, Junli Feng, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses
Pia Dosenovic, Anna-Klara Pettersson, Abigail Wall, et al.
Nature Communications
|
June 9, 2026
Diverse germline-targeting HIV Env immunogens select for distinct mutations in the same knock-in mice B cell receptors
Parul Agrawal, Junli Feng, Latha Kallur Siddaramaiah, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (New York, N.Y.)
|
March 26, 2021
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes
Tara Bancroft, Blair L DeBuysscher, Connor Weidle, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
Emilie Seydoux, Leah J Homad, Anna J MacCamy, et al.
Immunity
|
June 21, 2020
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
Emilie Seydoux, Leah J Homad, Anna J MacCamy, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
Phillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Science Advances
|
May 4, 2022
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
Matthew D Gray, Junli Feng, Connor E Weidle, et al.
Cell Reports
|
May 5, 2021
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
Emilie Seydoux, Yu-Hsin Wan, Junli Feng, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses
Pia Dosenovic, Anna-Klara Pettersson, Abigail Wall, et al.
Nature Communications
|
June 9, 2026
Diverse germline-targeting HIV Env immunogens select for distinct mutations in the same knock-in mice B cell receptors
Parul Agrawal, Junli Feng, Latha Kallur Siddaramaiah, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (New York, N.Y.)
|
March 26, 2021
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes
Tara Bancroft, Blair L DeBuysscher, Connor Weidle, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
Emilie Seydoux, Leah J Homad, Anna J MacCamy, et al.
Immunity
|
June 21, 2020
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
Emilie Seydoux, Leah J Homad, Anna J MacCamy, et al.
Page
of 9